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INTRODUCTION 
Perforating dermatoses represents a heterogenous group of disorders 
characterized by transepithelial elimination of dermal structures. 
Transepithelial elimination (TEE) is the process in which material from 
the dermis is extruded through the epidermis to the exterior with little or no 
disruption of the surrounding structures. The extruded material may include 
inflammatory cells, red cells, microorganisms and extracellular substances, such 
as mucin or altered connective tissue components.1 
Perforating dermatoses can occur in various clinical settings. 
1. As primary perforating dermatoses  
2. Associated with systemic diseases 
3. As a secondary component of primary dermatoses 
1. Primary perforating dermatoses 
a. Kyrle’s disease (hyperkeratosis follicularis et parafollicularis in 
cutem penetrans)  
b. Reactive perforating collagenosis (RPC)  
c. Elastosis perforans serpiginosa(EPS)  
d. Perforating folliculitis( PF).  
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2. Associated with systemic diseases 
Acquired perforating dermatoses, initially, it was described in association 
with renal disease and /or diabetes mellitus. But in recent years, it has 
been reported in patients with malignant,2,3 hepatic4, endocrinological 
disorders,4 AIDS,5 tuberculosis,6 pulmonary aspergillosis,7 
neurodermatitis,4 atopic dermatitis8 and scabies.9The clinical and 
histopathological findings may resemble any of  these four primary 
perforating dermatoses (Kyrle’s, RPC, EPS, PF).10 
3. As a secondary component in primary dermatoses 
Transepithelial elimination can occur as a secondary component of 
primary diseases such as granuloma annulare, pseudoxanthoma 
elasticum, chondrodermatitis nodularis helices, lichen nitidus, lichen 
planus, keratoacanthomas and necrobiosis lipoidica. 
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REVIEW OF LITERATURE 
HISTORY 11 
1916 - Kyrle’s disease was described by Kyrle as hyperkeratosis follicularis et      
parafollicularis in cutem penetrans. 
1953 - Elastosis perforans serpiginosa(EPS) was described by Lutz as keratosis 
follicularis serpiginosa.  
 1955 - Meischer described the histologic findings, naming it Elastoma 
intrapapillare perforans verruciforme. 
1967 - Reactive perforating collagenosis(RPC) was first reported in a child by   
Mehregan, Schwartz and Livingood.  
1968 - Perforating folliculitis (PF) was included in the primary perforating 
dermatoses by Mehregan and Coskey.  
1976 – Formerly known as pseudoxanthoma elasticum coexisting with elastosis 
perforans serpiginosa, periumbilical perforating pseudoxanthoma elasticum was 
redescribed later by Lund and Gilbert as a distinct entity.12 
1979 – The term periumbilical perforating pseudoxanthoma elasticum was first 
proposed by Hicks et al.13 
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Later Neldner and Martinez-Hernandez proposed the term “Localized acquired 
cutaneous pseudoxanthoma elasticum“, as they believed the process was 
“acquired” and was lacking “systemic involvement”.14 
EPIDEMIOLOGICAL ASPECTS OF PERFORATING DERMATOSES 
Incidence  
The perforating diseases are found worldwide. In patients receiving dialysis, 
acquired perforating dermatosis is rather common, with a prevalence of about 
11%.15 
Race  
 Perforating calcific elastosis (Periumbilical perforating pseudoxanthoma 
elasticum) is common in black women.16 
Familial form 
Childhood form of reactive perforating collagenosis is often familial.17 
Childhood elastosis perforans serpiginosa is occasionally familial.18 
Inheritance pattern 
Reactive perforating collagenosis – Both autosomal dominant and autosomal 
recessive.19 
Elastosis perforans serpiginosa  -  Autosomal dominant.20 
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Kyrle’s disease  –  Autosomal recessive.21 
Age  
Inherited type  –  childhood or early adulthood. 
Acquired type  –  middle aged adults. 
Sex  
Elastosis perforans serpiginosa mainly affects nearly four times more men than 
women.  
But in reactive perforating collagenosis and acquired perforating dermatoses the 
sex distribution is equal.  
Perforating folliculitis is said to be more common in women.11 
In Kyrle’s disease, a female preponderance is noted in some series.2 
Perforating periumbilical calcific elastosis is seen predominantly in women.16 
Seasonal variation  
Recurrences in winter and cold exacerbation is present in familial reactive 
perforating collagenosis.23 One study reported frequent recurrences in summer 
than in winter owing to longer duration of the former in a case of familial 
reactive perforating collagenosis.24 
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ETIOPATHOGENESIS OF PERFORATING DERMATOSES 
     The precise etiopathogenesis for the perforating disorder is unknown. 
    Epithelium becomes hyperplastic and eventually surrounds the abnormal 
connective tissue, just as it appears to do with wood splinters or other foreign 
bodies. 
    Primarily perforating diseases may be due to either genetic or acquired 
abnormalities of collagen or elastic fibers. 
     Fibronectin levels have been shown to be increased in the serum of patients 
with diabetes mellitus and uremia, and it has also been found to be increased in 
the skin at sites of perforating lesions.25This may be significant, since 
fibronectin plays a role in epithelial cell signaling, locomotion and 
differentiation. It binds to type IV collagen (the type found in basement 
membrane) and to keratinocytes, and may incite epithelial proliferation and 
perforation. 
Increased expression of TGF-β3 has also been observed in the epidermis 
and dermis near the sites of perforation in reactive perforating collagenosis, but 
this enhanced expression occurs in general wound healing reactions as well.26 
      Other proposed pathomechanisms include abnormal vitamin A 
metabolism,27 enzyme release from neutrophils,28 microangiopathy related 
diabetes, salt water chemical burns29 and an imbalance in the expression of 
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metalloproteinases and their tissue inhibitors. The metalloproteinases is 
assumed to influence the transepithelial channel formation by loosening the 
interkeratinocyte bonds, disrupting the basement membrane, and detaching the 
collagen fibers. This is supported by increased levels of metalloproteinases after 
epidermal injury (ex.scratching) after hypoxic condition or in diabetes state.9 
Deposition of substances such as uric acid, hydroxyapatite, silicon30 or other 
materials31 has also been implicated in the pathogenesis of perforating disorders. 
 Trauma is a major trigger of perforating disorders, although the molecular 
basis to explain the development of lesions after trauma is unclear. Many 
patients exhibit the Koebner phenomenon, and lesions can be produced 
experimentally by traumatizing the skin32 and after laser hair removal.33 
Kyrle’s disease 
 The exact etiopathogenesis of this disease is not well understood, but a 
genetic role has been suggested in some cases. Familial cases may occur.34 
Many cases occur in association with diabetes mellitus,35,36 chronic renal 
failure37  and liver disease.38 
 The primary event is claimed to be a disturbance of epidermal 
keratinization characterized by the formation of dyskeratotic foci and 
acceleration of the process of keratinization. This leads to the formation of 
keratotic plugs with areas of parakeratosis. Because the rapid rate of 
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differentiation and keratinization exceeds the rate of cell proliferation, the 
parakeratotic column gradually extends deeper into the abnormal epidermis 
leading to the perforation of the parakeratotic column into the dermis. The 
keratotic plug acts as a foreign body, penetrate the epidermis and incite a 
granulomatous inflammatory reaction.39 
Reactive perforating collagenosis 
 The cause is unknown but the condition is often familial.17,40 It is usually 
precipitated by environmental cold17 or trauma. It has been typically associated 
with diabetes and hemodialysis, also reported with hypothyroidism and 
hyperthyroidism, liver disorders, hodgkin’s lymphoma,2 treacher-collins 
syndrome,41 herpes zoster42,43 and periampullary carcinoma.44 
 An abnormal response to superficial trauma such as scratching may be 
implicated in the acquired form. This leads to focal damage to collagen, which 
then extruded as a result of necrolysis of the overlying epidermis.45 There is 
transepidermal elimination of histochemically altered collagen only, as the 
collagen fibrils appear intact with regular periodicity by electron microscopy.46 
Elastosis perforans serpiginosa 
 The cause of elastosis perforans serpiginosa is not known, but a 
genetically determined defect of elastic tissue may be involved in the idiopathic 
type.18 In some 40% of cases, there is an associated systemic condition or 
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connective tissue disorder, such as Down’s syndrome,47,48 osteogenesis 
imperfecta,49 cutis laxa,50 Ehler’s Danlos syndrome, Marfan’s syndrome, 
acrogeria,51 scleroderma,52 Pseudoxanthoma elasticum, Rothmund Thomson 
syndrome,53  diabetes54 and renal failure.55 Similar cutaneous lesions have been 
reported in patients with Wilson’s disease and cystinuria receiving long term 
penicillamine therapy.50,56,57 
 The thickened elastic fibers act as mechanical irritants or “foreign bodies“ 
and provoke an epidermal response in the form of hyperplasia. The epidermis 
then envelops the irritating material and eliminates it through transepidermal 
channels. The degeneration of the elastic fibers within the channels probably is 
caused by proteolytic enzymes set free by degenerating inflammatory 
cells.53The channel is formed as a reactive phenomenon through which the 
foreign bodies are extruded. 
 In patients on penicillamine therapy, a local copper depletion or a direct 
effect of penicillamine on elastin synthesis – disruption of desmosine cross links 
within elastin may be responsible for the formation of the abnormal elastic 
fibers which are then eliminated transepidermally.56,58 
 Elastic tissue damage appears to occur in other organs as well, a feature 
generally lacking in the usual idiopathic form of the disease.58,59 The nature of 
the defect in the idiopathic form is unknown, but it is possible that perforating 
elastosis is the final common pathway for more than one abnormality of elastic 
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fibers.60,10 This theory is compatible with the recent finding of an elastin 
receptor in keratinocytes immediately surrounding the elastic materials being 
eliminated in lesions of elastosis perforans serpiginosa. The elastin receptor may 
be involved in the interaction between keratinocytes and elastin.61 
Perforating folliculitis 
The etiology of perforating folliculitis is unknown, although minor 
mechanical trauma may play a role. It can occur as an isolated finding unrelated 
to other disease states and also be associated with renal failure often with 
hemodialysis,62 psoriasis,63 juvenile acanthosis nigicans, human 
immunodeficiency virus (HIV) infection64  and primary sclerosing cholangitis.65 
 Perforating folliculitis is the end result of abnormal follicular 
keratinization that most likely is caused by chemical or physical irritation and 
even chronic rubbing. A portion of a curled up hair is often seen close to or 
within the area of perforation or even in the dermis, surrounded by a foreign 
body granuloma.39  Mehregan first proposed that curled hairs within follicular 
canals may act as springs penetrating the lateral follicular wall, thereby 
initiating the process of transepithelial elimination.66 Support  for this concept 
has been provided by an ultrastructural study of acquired perforating dermatoses 
that showed hair fragments within transepidermal channels, even in patients in 
whom follicular involvement was not demonstrable on routine light microscopy. 
Factors that may promote coiling of hair include follicular hyperkeratosis 
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(occasional perforated follicles can be identified in keratosis pilaris) or contact 
dermatitis (ex.resulting from formaldehyde in clothing). 
Acquired perforating dermatoses  
 Several theories have been proposed for the pathogenesis of acquired 
perforating dermatoses. Microtrauma due to pruritus and scratching,67 diabetes 
mellitus related microangiopathy,68 epidermal or dermal change related to 
metabolic derangements69,70 and deposition of substances that cannot be 
removed with dialysis62 are the most commonly proposed theories. 
Perforating calcific elastosis 
The etiologic nature of perforating calcific elastosis has been debated. 
Some hypothesize that it is an acquired lesion developing as a consequence of 
local cutaneous trauma from such factors as obesity, multiple pregnancies, 
ascites, or multiple abdominal surgeries.13,14,71 It has been suggested that the 
stretching of the skin due to repeated pregnancies, obesity and abdominal 
surgeries promote elastic fibres degeneration resulting in perforating calcific 
elastosis.72 Association with chronic renal failure has been noted with apparent 
regression of skin lesions after hemodialysis.73 
Others have argued that perforating calcific elastosis may represent a 
localized cutaneous expression of hereditary pseudoxanthoma elasticum.74The 
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disorder may represent a spectrum ranging from a purely acquired form with no 
systemic manifestation to an inherited form with limited systemic expression. 
CLINICAL FEATURES 
Kyrle’s disease 
 Kyrle’s disease, as traditionally described, consists of hyperkeratotic 
papules 2 to 8 mm in diameter containing a central cone shaped plug.75,76 They 
are multiple, discrete or confluent and they may coalesce to form a verrucous 
plaque,77 large irregular or circinate lesions.38  The papules may be follicular or 
extrafollicular in location and brownish black in colour. There is a predilection 
for the lower extremities but lesions may also occur on the upper limbs and less 
often on the head and neck.76,78 Palmar and plantar surfaces are rarely 
involved.79 Lesions have even been described on the conjunctiva and buccal 
mucosa.80 Koebner phenomenon may occur, especially in the cubital and 
popliteal fossae. Onset is usually in the fourth decade. 
Reactive perforating collagenosis 
 The inherited form starts in infancy and early childhood. After superficial 
trauma, patient develop pin head sized skin coloured papules that grow to a 
diameter of about 6 mm over the following 3 to 5 weeks and then develop a 
central area of umbilication in which keratinous material is lodged. The discrete 
papules may be numerous and involve sites of frequent trauma such as backs of 
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hands, forearms, elbows and knees.45 The sole of the foot is a rare site.81 The 
lesions regress spontaneously in 6 to 8 weeks to leave a hypopigmented area or 
slight scar usually varioliform in nature. New lesions develop as older lesions 
are involuting and this may continue into adult life.82 
 There is often a history of superficial trauma; such as a scratch or insect 
bite.45,83 Lesions have been induced experimentally by trauma.32 The papules 
can also be provoked by inflamed acne lesions; but deep incisions do not 
produce these lesions. 
 The acquired form occurs in adults with history of diabetes mellitus and 
renal failure and may be associated with intense pruritus. 
Elastosis perforans serpiginosa 
 Elastosis perforans serpiginosa is a rare disorder beginning during 
childhood or early adulthood i.e 6 to 20 years. 
 Skin lesions consist of hyperkeratotic or umbilicated papules ranging 
from 2mm to 5 mm characteristically arranged in a linear, serpiginous or 
circinate pattern. Skin within these serpiginous arcs is often atrophic. The 
individual papules may remain small or may enlarge slightly to assume a 
crateriform appearance with an elevated edge and a central plug. The annular 
rings may reach a diameter of 15 to 20 cm but are usually smaller. Most patients 
experience no symptoms or only mild pruritus.53,84 
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 The most common site of involvement are back and sides of neck, but the 
lesions may also occur on the cheeks, arms or thighs and trunk and are 
sometimes generally symmetrical. Rarely, the lesions are generalized.85,86 They 
may persist for several years but eventually involute spontaneously to leave 
reticulate atrophic scars. Biopsy scars readily become keloidal. 
In rare instances, elastic tissue in the endocardium, bronchiolar walls, and 
arteries is involved. Rupture of the aorta has been reported.59 
Perforating folliculitis 
Perforating folliculitis is a perforating disorder that has many features 
overlapping with Kyrle’s disease. This relatively uncommon disorder is usually 
observed in the second to fourth decades of life. 
 It is manifested by discrete, 2 – 8 mm diameter scaly keratotic 
folliculocentric papules with small central keratotic plugs and varying degrees 
of erythema. Compression of papules may yield keratin debris and a coiled hair 
or hair fragments. There is a predilection for the extensor surfaces of the 
extremities and the buttocks.60 It may persists for months or years; although 
periods of remission often occur.  
 Often lesions are asymptomatic, although pruritus may be a striking 
feature, especially in patients with renal insufficiency. The Koebner 
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phenomenon usually is not readily demonstrable, but a linear configuration 
occasionally can be observed. 
 A case of progressive generalized perforating folliculitis has been 
reported to be associated with erythroderma, keratoderma of the palms and 
soles, alopecia of the scalp and eyebrows, and nail changes. Accompanying 
jaundice has been observed in patients with underlying liver disease.87 
Acquired perforating dermatosis 
 Acquired perforating dermatosis has been used as a catch all term for 
those examples of perforating disease arising in adults, usually in association 
with diabetes mellitus and or the pruritus of renal failure. 
 Clinically, the lesions range from hyperkeratotic  papules and nodules 
containing a central cone shaped plug resembling kyrle’s disease to reactive 
perforating collagenosis – like hyperkeratotic, plugged, umbilicated  papules,  
nodules and plaques to erythematous, follicular infiltrating papules and nodules 
mimicking perforating folliculitis. Annular plaques and erythematous pustules 
have also been described, with histologic features of reactive perforating 
collagenosis and perforating folliculitis, respectively. 
 Extensor surfaces of the lower extremities were the most commonly 
involved site, followed by the upper extremities, trunk and head. The lesions are 
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frequently pruritic and scratching can lead to a koebner phenomenon with linear 
umbilicated papules arising in excoriated skin.88 
Perforating calcific elastosis 
The onset of the disease is in the fifth to sixth decade of life in 
perimenopausal women.89These localized lesions usually occur in the 
periumbilical area in obese, multiparous black women16 and rarely over the 
breast.90 Most reported cases have been hypertensive.73 
Initial eruption may contain asymptomatic or mildly pruritic 
erythematous papules, plaques or nodules. Over the course of several months or 
years, the lesions tend to resolve, leaving a well demarcated, hyperpigmented, 
reticulate, atrophic central plaque with raised, scaly border. Discrete, horny, 
hyperkeratotic papules may be scattered around the periphery. Lesions range in 
size from 2 – 15 cm and may be circular or oval.90  
None of the systemic features of pseudoxanthoma elasticum occurs in 
perforating calcific elastosis. 
HISTOPATHOLOGY 
 In all the perforating diseases, transepithelial elimination is the final 
common pathway whereby the altered dermal substances are extruded. There is 
a plug of crusting or hyperkeratosis, with variable parakeratosis, depending 
upon the stage of the lesion. 
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 Sections from multiple levels through the tissue may need to be examined 
to find the site of perforation. Early lesions of even typical perforating 
dermatoses may not show typical features. Early stage showed exocytosis of 
inflammatory cells and alteration of elastic fibers in dermis, while evidence of 
perforation in basement membrane was evident only in older lesions.91 
 The special stains such as Verhoeff Van Gieson (VVG) and Masson 
Trichrome stains are most helpful. In VVG stain, collagen fibers appear red and 
elastic fibers black. In Masson Trichrome collagen fibers are stained blue or 
green. 
Kyrle’s disease92,93 
The essential histopathologic findings include, 
1. A follicular or extrafollicular cornified plug with focal parakeratosis 
embedded in an epidermal invagination. 
2. Basophilic cellular debris in the plug which does not stain for collagen 
and elastic fibers. 
3. Abnormal vacuolated and /or dyskeratotic cells extending to the basal cell 
layer. 
4. Irregular epithelial hyperplasia. 
5. A pronounced granulomatous reaction composed of inflammatory cells 
such as lymphocytes, occasional neutrophils and sometimes a few foreign 
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body giant cells seen when the keratotic plug is in contact with the 
dermis. 
Follicular involvement present, particularly in those with chronic renal 
failure where overlap with perforating folliculitis occurs. Eccrine duct 
involvement was present in one atypical case reported in the literature.79 
Reactive perforating collagenosis45,67,94 
 The appearances vary with the stage of evolution of the lesion. In early 
lesions, there is acanthosis of the epidermis and an accumulation of basophilic 
collagen in the dermal papillae. 
 In established lesions, there is a vertically oriented, shallow cup shaped 
invagination of the epidermis, forming a short channel filled with a plug 
consisting of parakeratotic keratin, basophilically altered collagen bundles and 
inflammatory debris. The channel is lined by acanthotic epithelium along the 
sides. The underlying epidermis is thin with fine slits through which basophilic 
collagen fibers in vertical orientation are extruded. Sometimes there is a 
complete break in the epidermis.95 Nuclear material derived from neutrophils, 
and neutrophils themselves, are present in the extruded material.6,96 
Masson trichrome stain must be done to confirm that the fibers are collagen. 
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Elastosis perforans serpiginosa53,60,94,97 
The earliest change is the development of elastotic staining tissue and 
basophilic debris in the dermis that is engulfed by the overlying epidermis. 
In fully developed lesions, there is a localized area of hyperplastic 
epidermis, associated with a narrow channel that may be straight, wavy or of 
corkscrew shape through which the basophilic nuclear debris and brightly 
eosinophilic thick coarse fragmented elastic fibers are being eliminated. A 
keratinous plug usually overlies this channel, which may take the form of a 
dilated infundibular structure or a more oblique canal coursing through the 
hyperplastic epidermis, follicular epithelium or the acrosyringium. An 
inflammatory cell infiltrate accompanies the fibers in the channel. 
Abnormal elastic fibers are seen in the upper dermis in the vicinity of the 
channel. In this zone, the elastic fibers are increased in size and number. As 
these fibers enter the lower portion of the channel, they maintain their normal 
staining characteristics, but as they approach the epidermal surface, they may 
not stain as expected with elastic stains and become brightly eosinophilic. They 
will stain with the Giemsa method. 
A few foreign body giant cells and inflammatory cells are often present in 
the dermis adjacent to the channel. In older lesions, there is focal dermal 
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scarring and usually an absence of elastic fibers. Verhoeff van Gieson stain is 
used for elastic fibers which stains it black in colour. 
In penicillamine related cases, there is an increased number of thickened 
elastic fibers in the reticular dermis and less hyperplasia of elastic fibers in the 
papillary dermis, except in the areas of active transepidermal elimination.98 The 
elastic fibers are irregular in outline with buds and serrations. This may be 
discerned in haematoxylin and eosin stained preparations, but it is well shown 
by elastic tissue stains99 or in Epon – embedded thin sections stained with 
toluidine blue.58 
Perforating folliculitis100,60 
 The main pathologic abnormalities consist of: 
 1. A dilated follicular infundibulum filled with compact ortho and 
parakeratotic cornified cells. 
 2.  Degenerated basophilic staining material, comprised of granular 
nuclear debris from nuclear neutrophils, other inflammatory cells, and 
degenerated collagen bundles. 
 3. The follicular epithelium is disrupted in one or more areas in the 
infundibulum. 
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4. The adjacent dermis shows degenerative changes involving the 
connective tissue, and sometimes the altered collagen and refractile 
eosinophilically altered elastic fibers are seen entering the perforation. 
 5. A variable perifollicular inflammatory cell infiltrate composed of 
lymphocytes, histiocytes; and neutophils is present in the dermis. 
 6. A curled hair shaft is sometimes present. 
Acquired perforating dermatosis 
 Biopsy findings in acquired perforating dermatosis vary according to the 
stage of evolution of the lesion. They may resemble any one of the primary 
perforating disorders. In other cases it may be less specific, with amorphous 
degenerated material within the perforations. This material often cannot be 
clearly identified as collagen or elastic fibers, but sometimes both are present.10 
 Epidermal invagination filled with keratotic plug admixed with cellular 
debris and neutrophils in the absence of follicular involvement, without 
demonstrable collagen or elastin is reminiscent of Kyrle’s disease. When 
vertically oriented collagen, Masson trichrome positive collagen bundles are 
present within a perforation, the findings are suggestive of reactive perforating 
collagenosis. When perforation is associated with a follicle, the findings 
resemble perforating folliculitis. Perforation associated with elastic Van Gieson 
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positive elastic fibers within a transepidermal channel, as seen in elastosis 
perforans serpiginosa, has also been described.55,88 
Patterson et al63 reported a patient who had multiple lesions biopsied, 
which variably showed histologic features of reactive perforating collagenosis, 
perforating folliculitis, and Kyrle’s disease. Moreover, Rapini and coworkers10 
reported combined transepidermal elimination of both collagen and elastin in 
their four patients with acquired perforating dermatosis. 
Perforating calcific elastosis 
Histological examination reveals numerous altered basophilic elastic 
fibres in the reticular dermis. They are short, thick, frayed, curled and are 
encrusted with calcium salts. Von Kossa stain is used to stain calcium.39 
Channels extruding inflammatory and elastotic debris from the reticular dermis 
to the overlying epidermis is seen. Eosinophilic intrapapillary elastoma may 
also be observed.72 
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AIM OF THE STUDY 
1. To find out the incidence of perforating dermatoses among patients 
attending the skin OPD. 
 
2. To delineate the clinical and histopathological features of various types of 
perforating dermatoses. 
 
3. To find out the potential relationship existing between the perforating 
dermatoses and systemic disease. 
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MATERIALS AND METHODS 
 
The material for this study was from the patients attending the skin OPD, 
Government Rajaji Hospital, Madurai Medical College, Madurai during the 
period from June 2008 to June 2010. 
Inclusion criteria 
All patients diagnosed clinically as perforating dermatoses and supported by 
histopathological examination. 
Exclusion criteria 
1. Patients who were unwilling for the study. 
A detailed history was elicited with particular reference to age of onset, 
duration, site, morphology of lesions, progression, presence or absence of 
itching, systemic symptoms, occupation and family history. Detailed history of 
diabetes, renal failure, liver disease, endocrinological disorder and internal 
malignancy were also recorded. 
A thorough general examination, systemic examination and dermatological 
examination were done. Digital photographs were taken. 
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Detailed examination of skin lesion which includes morphology of skin 
lesions, distribution of lesions, number of lesions, pigmentary changes and 
scarring were all recorded. 
Laboratory investigations like blood sugar, urea, serum creatinine, liver 
function tests, urine examination, serology for human immunodeficiency virus 
(HIV), hepatitis (HBV, HCV) and complete hemogram were done. Special 
investigations like thyroid profile, serum calcium and ultrasonogram were 
performed wherever necessary. 
Skin biopsies were done after getting informed consent. After thorough 
cleaning of the selected part with spirit or povidone iodine solution, the area 
was infiltrated with 2% lignocaine and a bit of the lesional skin was removed by 
punch biopsy. The specimens were preserved in 10% formalin and submitted 
for histopathological examination to the department of Pathology, Madurai 
Medical College. Specimens were studied with routine haematoxylin & eosin 
stain and special stains like Verhoeff van Gieson, Masson trichrome and Von 
Kossa wherever necessary. 
A descriptive analysis of the clinical features, laboratory parameters and 
histopathological features of various perforating dermatoses was done. The data 
was analyzed and compared with published literature. 
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OBSERVATIONS AND RESULTS 
Thirty five patients with clinical features of perforating dermatoses were 
seen during the study period from June 2008 to June 2010. Out of these, 5 
patients were excluded from the study as they were not willing for the skin 
biopsy. 
Thirty patients with clinical and histopathological features of perforating 
dermatoses were included in the study. The following observations were made. 
Table 1:  Types of perforating dermatoses 
Types of perforating 
dermatoses 
No. of 
patients 
Percentage (%)
Kyrle’s disease 16 54% 
Reactive perforating 
collagenosis 
13 43% 
Perforating calcific 
elastosis 
1 3% 
Total  30 100% 
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Kyrle’s disease was the commonest type (54%) followed by reactive perforating 
collagenosis (43%) and perforating calcific elastosis (3%). 
Table 2:  
Types of perforating 
dermatoses 
Inherited  Acquired 
Kyrle’s disease - 16 
Reactive perforating 
collagenosis 
9 4 
Perforating calcific 
elastosis 
- 1 
Total  9 21 
 
Among the perforating dermatoses, acquired form (70%) was more common 
than inherited form (30%). 
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AGE DISTRIBUTION  
The age of onset in the acquired group was 
Table 3:  
Age of 
onset 
KD RPC PCE Total  Percentage  
0 – 10 - - - - - 
11 – 20   - - - - - 
21 – 30  1 - - 1 5 
31 – 40  2 2 - 4 19 
41 – 50  5 - 1 6 29 
51 – 60  6 1 - 7 33 
61 – 70  2 1 - 3 14 
Total  16 4 1 21 100 
 
KD - Kyrle’s disease  
RPC –Reactive perforating collagenosis 
PCE – Perforating calcific elastosis 
The age of onset of majority of the patients (62%) in the acquired group was 
between 41 – 60 years. 
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The age of onset in the inherited group was 
Table 4: 
Age of onset RPC Percentage 
(%)  
0 – 10  2 22 
11 – 20  7 78 
Total  9 100 
 
RPC –Reactive perforating collagenosis 
The age of onset of majority of the patients (78%) in the inherited group was 
between 11 – 20 years. 
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Table 5: Age at presentation 
Age at presentation  Inherited Acquired 
0 – 10 - - 
11 – 20 1 - 
21 – 30  2 1 
31 – 40 4 4 
41 – 50 - 6 
51 – 60 2 7 
61 – 70 - 3 
Total  9 21 
 
According to our study, in the inherited group, 67% of the patients were 
between 21 – 40 years of age when they presented to us. 
In the acquired form, the age at presentation of majority of the patients (62%) 
were between 41 – 60 years. 
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SEX DISTRIBUTION 
20 patients were males and 10 patients were females. 
Table 6: Sex distribution 
Types of 
perforating 
dermatoses 
Male  Female  
Kyrle’s disease 11 5 
Reactive 
perforating 
collagenosis 
9 4 
Perforating calcific 
elastosis 
- 1 
Total  20 10 
 
FAMILY HISTORY 
Family history of perforating dermatoses was present in all the 9 cases (100%) 
in the inherited group. 
SEASONAL VARIATION 
Cold exacerbation was seen in 5 patients (56%) with familial reactive 
perforating collagenosis. 
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DURATION 
The mean duration of disease was 7 years, with a maximum of 46 years and a 
minimum of 1 month. 
MORPHOLOGY 
Different types of lesions were observed. In 16 (53%) of the patients, the lesions 
were hyperkeratotic papules and in 13 (43%) hyperkeratotic, plugged, 
umbilicated papules and plaques were apparent.  Erythematous papules 
arranged in annular and serpiginous pattern in the periphery of the central 
atrophic plaques were noted in 1 patient (3%). 
DISTRIBUTION 
Table 7: Site of involvement 
Region  No. of patients Percentage (%) 
Head  5 23 
Trunk  17 57 
Upper extremities 19 63 
Lower extremities 22 73 
 
Lower extremities (73%) were the most commonly involved site, followed by 
the upper extremities (63%), trunk (57%) and head (23%). 
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SYMPTOMS 
The presenting symptoms of the patients were itching in 63% and pain in 7%. 
30% of patients were asymptomatic. 
Table 8: Symptoms 
Symptoms No: of patients  Percentage (%) 
Itching  19 63% 
Pain 2 7% 
Asymptomatic  9 30% 
Total  30 100% 
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KOEBNER PHENOMENON 
Koebner phenomenon was seen in 16 (53%) patients. 
Table 9: 
Types of perforating 
dermatoses 
Total no. of patients No. of patients with 
koebner phenomenon 
KD 16 10 
RPC 13 6 
PCE 1 - 
Total 30 16 
 
KD - Kyrle’s disease  
RPC –Reactive perforating collagenosis 
PCE – Perforating calcific elastosis 
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HISTOPATHOLOGY 
Table 10: Biopsy findings 
Biopsy findings KD RPC PCE 
Parakeratosis 12 8 - 
Hyperkeratosis  16 10 1 
Keratotic plugging 15 9 1 
Acanthosis  16 11 1 
Dyskeratotic cells 5 - - 
Transepidermal channel    
Keratin 16 9 1 
Cellular debris 13 7 1 
Altered collagen fibers - 13 - 
Altered elastic fibers - - 1 
Papillary dermis    
Lymphocytes 10 4 1 
Neutrophils  12 6 1 
Altered collagen fibers - 13 - 
Altered elastic fibers - - - 
Reticular dermis    
Altered elastic fibers - - 1 
 
KD - Kyrle’s disease 
RPC –Reactive perforating collagenosis 
PCE – Perforating calcific elastosis  
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Histopathological evaluations revealed three types of lesions. 
1. Histopathological features of 16 (54%) cases showed epidermal 
invagination filled with keratotic plug admixed with cellular debris and 
neutrophils. In biopsy specimens of these 16 patients, Masson trichrome 
and elastic van Gieson stains were negative in the epidermis and in the 
crater. Hence, the overall histological appearance in these 16 cases was 
consistent with Kyrle’s disease. 
2. Histopathological features of 13 (43%) cases showed cup shaped 
invagination of the epidermis filled with a plug consisting of keratin, 
cellular debris and neutrophils. There were vertically oriented collagen 
bundles at the base of the lesions in five of these thirteen cases. Masson 
trichrome staining showed transepidermal elimination of collagen in all 
these thirteen cases. Elastic van Gieson stains were negative in the 
epidermis and in the crater. The overall histological appearance in these 
13 cases was consistent with reactive perforating collagenosis. 
3. In the last case, numerous altered basophilic elastic fibres encrusted with 
calcium salts seen in the reticular dermis. Von kossa stain was used to 
stain the calcium. Channels extruding inflammatory and elastotic debris 
from the reticular dermis to the overlying epidermis was also seen. 
Verhoeff van Gieson stain was used to stain the elastic fibres. The overall 
37 
 
histological appearance in this case was consistent with perforating 
calcific elastosis. 
ASSOCIATED DISEASES 
Table 11: Associated diseases 
Types of 
perforating 
dermatoses 
DM CRF HYPOTHR HT 
Kyrle’s disease 12 11 1 - 
Reactive 
perforating 
collagenosis 
4 - - - 
Perforating 
calcific elastosis 
- - - 1 
Total  16 11 1 1 
  
DM – Diabetes mellitus 
CRF – Chronic renal failure 
HYPOTHR  - Hypothyroidism 
HT – Hypertension 
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Twenty (67%) patients had at least one systemic disease. The commonest 
association was diabetes mellitus followed by chronic renal failure, 
hypothyroidism and hypertension.  
Of the 16 patients with diabetes mellitus, 2 (12.5%) had insulin dependent 
diabetes mellitus (IDDM), and 14(87.5%) had non-insulin dependent diabetes 
mellitus (NIDDM). 
Five of eleven chronic renal failure patients (45%) were on hemodialysis 
treatment. 
In 9 of 11 patients (82%) with chronic renal failure, the cause of kidney disease 
was diabetes mellitus, and in 2 (18%) glomerulonephritis. 
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DISCUSSION 
The study was conducted during the period June 2008 to June 2010 at the 
Department of Dermatology, Government Rajaji Hospital, Madurai Medical 
College, Madurai. 
Incidence  
30 cases of perforating dermatoses were diagnosed in about 1,15,368 
patients who attended the skin OPD during the period of study. 
In our study, kyrle’s disease was the commonest type (54%) followed by 
reactive perforating collagenosis (43%) and perforating calcific elastosis (3%). 
Acquired type (70%) was more common compared to inherited form (30%). 
In our study, only reactive perforating collagenosis was seen in the 
inherited form. Kyrle’s disease was not seen. Joseph et al101, in his study, 
reported that kyrle’s disease is always associated with a systemic disorder and 
seen only in acquired perforating dermatoses. But its occurrence in a familial 
setting is also reported by Viswanathan S et al21 and Aram et al36 in their 
studies. 
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Age distribution 
The age of onset of lesions in the majority of acquired perforating 
dermatoses patients (62%) were between 41 – 60 years which is similar to study 
by Saray et al88. 
In our study, majority of patients of kyrle’s disease fall in the age group 
from 41-60 years whereas Joseph et al in his study observed 31-50 years as 
common age group. The majority of familial reactive perforating collagenosis 
patients (78%) had the onset of lesions between 11 – 20 years of age as against 
0 - 10 years reported by Bhat YJ et al.23  
According to our study, in the inherited group, 67% of the patients were 
between 21 – 40 years of age, when they presented to us. Even though the onset 
was earlier, they presented to us at a later period only. This may be due to the 
asymptomatic nature of the disease. 
Sex distribution 
Preponderance of males was noted in our study which is in concordance 
with the study by Saray et al. On analyzing the incidence in the literature, it is 
varied in different studies. The sex distribution is equal for acquired perforating 
dermatoses and reactive perforating collagenosis.11,23 In kyrle’s disease, a 
female preponderance has been noted in some series22  whereas Joseph et al  has 
recorded a equal sex distribution.   
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Family history 
In our study, family history of perforating dermatoses was present in all 
the 9 patients of inherited type. There was no family history in any of the 
patients with acquired perforating dermatoses. 
Seasonal variation 
Cold exacerbation was seen in 5 patients (56%) of familial reactive 
perforating collagenosis. This is in concordance with the study by Bhat YJ et al, 
who recorded 60% in their patients. But recurrences in summer has also been 
noted in the study by Ramesh V et al.24 
Trauma and cold induces the degeneration of collagen with thinning of 
epidermis in genetically predisposed individuals. 
Duration 
The mean duration of disease was 7 months for acquired perforating 
dermatoses which is similar to study by Saray et al. 
 Morphology  
The lesions of perforating dermatoses had varied morphologies 
resembling kyrle’s disease (hyperkeratotic papules) in 54%, reactive perforating 
collagenosis (umbilicated papules with central keratotic plug) in 43% and 
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perforating calcific elastosis (erythematous papules arranged in the periphery of 
a central atrophic plaque in annular and serpiginous pattern) in 3%. 
Distribution 
Lower extremities are the most commonly involved site in acquired 
perforating dermatoses as stated by Saray et al who reported a frequency of 73 
percent. This was the case in our study, with extensor surfaces of the lower 
extremities involvement in 17 patients (81%), upper extremities in 12 patients 
(57%), trunk in 11 patients (52%) and head in 3 patients (14%) of acquired 
perforating dermatoses. Multisite involvement was noted in 15 patients (71%). 
However unusual presentation on the face and scalp were also observed. 
In perforating calcific elastosis, Hicks et al13 and Kazakis et al102 
suggested that the traumatic effect of repeated pregnancies on elastic tissue 
explain the localization of skin lesion to the periumbilical area as observed in 
our patient. 
Symptoms 
Itching was the main complaint in 63% of our patients, which was most 
commonly encountered with acquired perforating dermatoses than with 
inherited form. Only one patient with familial reactive perforating collagenosis 
had pruritus. This patient with early onset (14 years of age) of skin lesions 
presented to us at the age of 60 years with large intensely pruritic lesions which 
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healed with scarring, indicating that the lesions become more profuse and 
enlarged with age unless treatment is given. Similar observations were also 
made by Kachhawa D et al103 and Bhat YJ et al in their studies. 
Two patients (7%) had pain, which is an unexpected symptom for 
acquired perforating dermatoses. Saray et al reported pain in 9 percent of 
patients in his study. 
Koebner phenomenon 
Koebnerization, which is frequently reported in perforating dermatoses, 
was observed in 53 percent of our patients. 
Among the patients with acquired perforating dermatoses, koebner’s 
phenomenon was present in 57% as against 32% reported by Saray et al. 
Frequent association of acquired perforating dermatoses lesion with pruritus, 
localization of the lesion mostly on the trauma prone areas, and presence of the 
koebner phenomenon in most of our cases suggest that mild superficial trauma 
(ex. scratching due to pruritus) may in fact be an important aetiological factor in 
the aetiopathogenesis of acquired perforating dermatoses. 
Histopathology 
As previously stated in the literature, we observed histopathological 
features consistent with each of the perforating dermatoses. 
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Kyrle like histopathological features were the most common (54%), 
followed by reactive perforating collagenosis (43%) which is in concordance 
with the study done by Saray et al. Perforating calcific elastosis like 
histopathological feature was noted in one patient.  
Patterson JW63 documented the lesions with histological features of 
perforating folliculitis, reactive perforating collagenosis and kyrle’s disease in 
the same patient with acquired perforating dermatoses. Moreover, Rapini and 
coworkers10 reported combined transepidermal elimination of both collagen and 
elastin in their four patients with acquired perforating dermatoses. 
They proposed that varying histological findings in this disease may 
represent the different stages or different types of lesions in the same 
pathological process. However, we did not observe such overlapping features in 
our patient group. Saray et al in their study also recorded the similar findings 
like our study.      
Moreover, it is also possible that we have been unable to observe the 
different stages of the histopathological evaluation because of the fact that we 
have taken only one biopsy from each patient. However, on the basis of 
distinctive histopathological findings with the absence of overlapping 
histopathological features in our study, we think that acquired perforating 
dermatoses consists of four different types of perforating disorders, namely, 
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kyrle’s disease, reactive perforating collagenosis, perforting folliculitis and 
elastosis perforans serpiginosa like perforating disorders. 
Patterson JW, in his study noted both collagen and elastin in the early, 
non umbilicated lesions, whereas collagen was observed in the umbilicated 
ones. Fibrous component was the only material eliminated in late lesions, 
probably due to the degeneration of both collagen and elastin. 
In contrast to these early findings, we observed neither collagen nor 
elastin elimination in most of the non umbilicated lesions. However, collagen 
elimination was observed in the umbilicated ones, which was similar to the 
findings in the above mentioned study.   
Associations 
In our study, majority (67%) of our patients had at least one systemic 
disease, and diabetes mellitus (76%) and chronic renal failure (52%) were the 
most common diseases associated with acquired perforating dermatoses. 
Two of our patients had insulin dependent diabetes mellitus (IDDM), and 
most (14) had non insulin dependent diabetes mellitus (NIDDM) similar to 
study by Saray et al. Other investigators4,104 have also found that NIDDM is 
more frequent in patients with acquired perforating dermatoses. In contrast, 
Morton and coworkers15 observed that acquired perforating dermatoses is more 
often associated with IDDM compared with NIDDM. 
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In diabetes mellitus, the proposed mechanism is that, trauma from 
scratching may cause dermal necrosis due to poor blood supply that results from 
vasculopathy, with necrotic material then being extruded through the 
epidermis.88 
Chronic renal failure was the second most frequent (52%) disease 
associated with acquired perforating dermatoses in the present study. In 9 of 
eleven patients (82%) with chronic renal failure, the cause of kidney disease 
was diabetes mellitus, and in 2 (18%) glomerulonephritis, findings similar to 
studies done by Saray et al and Joseph et al were seen. 
In the literature, epidermal or dermal abnormalities such as alterations in 
collagen or elastic fibres due to metabolic disturbances related to chronic renal 
failure have been suggested as underlying factors in acquired perforating 
dermatoses patients with chronic renal failure.88 
In patients with chronic renal failure, acquired perforating dermatoses 
often occurs following dialysis.15,104 However, the lesions may also start in the 
pretreatment period.15,60 In our study, acquired perforating dermatoses 
developed after the initiation of dialysis treatment in five patients with chronic 
renal failure. 
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 Hypothyroidism was associated in one patient with acquired perforating 
dermatoses. Association of acquired perforating dermatoses with 
hypothyroidism has been described in earlier studies by Faver IR et al.4 
Hypertension was seen in one patient with periumbilical perforating 
calcific elastosis, who was an obese, multiparous woman with no characteristic 
lesions and family history of pseudoxanthoma elasticum.  
There was no systemic association seen in any of our patients with 
familial reactive perforating collagenosis as described in earlier studies by Bhat 
YJ et al. 
Interesting observation 
An unusual finding of this study was that Kyrle’s disease was detected in 
one patient in whom neither a systemic disease nor any other dermatological 
problem was observed. There are only few reports of acquired perforating 
dermatoses occuring in otherwise healthy people.96,105 Kalla G et al106 and Saray 
et al have reported similar cases in their studies. 
 
 
 
48 
 
SUMMARY 
 Thirty patients, diagnosed with perforating dermatoses, based on history, 
clinical features and histopathology were included in the study. 
Incidence  
 The incidence was 1.3 per 10,000 among 1,15,368 new patients who 
attended the skin OPD during the period of study. 
 Kyrle’s disease was the commonest type (54%), followed by reactive 
perforating collagenosis (43%) and perforating calcific elastosis (3%). 
Age  
 78% of the patients in the inherited form had the onset of lesions between 
11 – 20 years. 
 62% of the acquired perforating dermatoses patients had the onset of 
lesions between 41 – 60 years. 
Sex 
 Preponderance of males was noted in our study. 
Family history 
 Family history of perforating dermatoses was present in all the 9 cases in 
the inherited group. 
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Seasonal variation 
 Winter exacerbation was seen in 56% of familial reactive perforating 
collagenosis patients. 
Morphology and distribution 
 Hyperkeratotic papules were present in 53%, umbilicated papules with 
keratotic plugging in 43% and annular atrophic plaque with erythematous 
papules in the periphery in 3% of the patients. 
 Lower extremities (73%) were the most commonly involved site, followed 
by the upper extremities (63%), trunk (57%) and head (23%). Multisite 
involvement was also common (71%). 
Symptoms  
 Pruritus was present in 63% and pain in 7% of our patients. 30% were 
asymptomatic. 
Koebner phenomenon 
 Koebner phenomenon was seen in 53% of our patients. 
Histopathology 
 Histopathological features consistent with kyrle’s disease were seen in 16 
patients, reactive perforating collagenosis in 13 patients and perforating calcific 
elastosis in one patient. 
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Associations 
 In this study, diabetes mellitus was the commonest associated disease, 
followed by chronic renal failure, hypothyroidism and hypertension. 
 Non insulin dependent diabetes mellitus (NIDDM) was more commonly 
seen than insulin dependent diabetes mellitus (IDDM). 
 The commonest cause of kidney disease in chronic renal failure patients 
was diabetes mellitus (82%), followed by glomerulonephritis (18%). 
 Interesting presentation of one case of acquired perforating dermatoses 
with no systemic association was seen. 
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CONCLUSION 
1. Perforating dermatoses is a rare skin disease comprising only a very small 
percentage of patients (1.3 per 10,000) attending the skin OPD. 
2. Kyrle’s disease is the most common perforating dermatoses, followed by 
reactive perforating collagenosis. 
3. The age of onset of skin lesions for majority of the patients in the inherited 
form is 11 – 20 years and in acquired, 41 – 60 years. 
4. Preponderance of males is noted. 
5. Lower extremities are the most frequent site of involvement. 
6. Clinicopathological examination is important in arriving at the diagnosis. 
7. Non insulin dependent diabetes mellitus is the most frequent association 
seen with acquired perforating dermatoses. 
8. In chronic renal failure patients with acquired perforating dermatoses, the 
contributing factors are either diabetes mellitus or hemodialysis. 
9. An interesting case of acquired perforating dermatoses with no systemic 
association is also noted. 
 
 
KEY TO MASTER CHART 
P = Present 
F.H = Family History 
COLD = Cold exacerbation 
MORP = Morphology 
1 = Keratotic plugged, umbilicated papules 
2 = Keratotic plugged, umbilicated papules and plaques 
3 = Hyperkeratotic papules 
4 = Erythematous papules arranged in the periphery of a central atrophic plaque 
in annular and serpiginous pattern 
DISTRIB = Distribution 
H = Head 
T = Trunk 
UL = Upper limb 
LL = Lower limb 
KOEB = Koebner phenomenon 
DM = Diabetes mellitus 
CRF = Chronic renal failure 
GN = Glomerulonephritis 
HD = Hemodialysis 
THY = Hypothyroidism 
IDDM = Insulin dependent diabetes mellitus 
NIDDM = Non insulin dependent diabetes mellitus 
DUR = Duration  
HP-E.M = Histopathology – Eliminated material 
KD = Kyrle’s disease 
RPC-I = Reactive perforating collagenosis – Inherited 
RPC-A = Reactive perforating collagenosis – Acquired  
PCE = Perforating calcific elastosis  
Yrs = years  
Mo = months 
 
S.NO NAME AGE/ F.H AGE OF DURATION SYMPTOMS COLD MORP SCAR DISTRIB KOEB HP‐E.M DIAGNOSIS
SEX  ONSET DM/DUR CRF/DUR OTHERS
1 Shanthi 27/F P 12 years 10 years _ P 1 P UL,LL,H _ _ _ _ Collagen RPC‐I
2 Chandran 56/M P 10 years 46 years _ _ 2 P LL,UL _ _ _ _ Collagen RPC‐I
3 Sophi 49/F _ 49 years 4 months Pruritus _ 3 _ UL,LL P NIDDM/4 yrs P/7 mo _ _ KD
4 Meenakshi 63/F _  63 years 1 month Pruritus _ 1 _ LL P NIDDM/10 yrs _ _ Collagen RPC‐A
5 Yasar Arafat 16/F P 14 years 2 years _ _ 1 _ UL,T _ _ _ _ Collagen RPC‐I
6 Alamelu 39/F _ 39 years 6 months Pruritus _ 3 _ LL P _ P/16 yrs HD/6 yrs _ KD
7 Ramar 35/M P 10 years 25 years _ _ 1 P T,UL,LL P _ _ _ Collagen RPC‐I
8 Krishnaveni 49/F _ 49 years 1 month Pruritus _ 3 _ LL,UL P _ P/3 yrs GN/5 yrs _ KD
9 Sudharsan 57/M _ 57 years 3 months Pruritus _ 1 _ LL P NIDDM/8 yrs _ _ Collagen RPC‐A
10 Fathima 40/F _ 38 years 2 years Pruritus _ 1 _ UL,LL _ NIDDM/6 yrs _ _ Collagen RPC‐A
11 Gnanam 44/M _ 44 years 1 month Pruritus _ 3 _ T,UL,LL P IDDM/2 yrs _ _ _ KD
12 Vellai 60/M _ 60 years 1 month Pruritus _ 3 _ UL,LL,T P NIDDM/15 yrs _ _ _ KD
13 Samsudeen 40/M _ 38 years 2 years Pruritus _ 3 P UL,T,LL _ _ _ _ _ KD
14 David 28/M P 17 years 11 years _ 1 _ UL _ _ _ _ Collagen RPC‐I
15 Saroja 52/F _ 52 years 1 month Pain  _ 3 _ UL,T,H _ NIDDM/2 yrs P/1 year HD/6 mo_ KD
ASSOCIATIONS
MASTER CHART 
COLOUR PLATES 
KYRLE’S  DISEASE 
                
Hyperkeratotic papules over thigh and back 
 
                          
Hyperkeratotic papules over gluteal region and knee joint 
 
 
 KYRLE’S DISEASE 
                                               
 
                                                 
 
Koebner phenomenon  over elbow and knee joint 
 
 
 
  
PERFORATING PERIUMBILICAL CALCIFIC 
ELASTOSIS 
             
 
 
 
 
 
 
 
 
 
 
REACTIVE PERFORATING COLLAGENOSIS 
                  
Umbilicated papules and plaques over leg and forearm 
            
Umbilicated papules and plaques over scalp 
 
 REACTIVE PERFORATING COLLAGENOSIS 
       
Umbilicated papules -arm,             Koebner phenomenon -  
back                                                plaque over leg 
 
           
Varioliform scarring over back and face 
 
 
 REACTIVE PERFORATING COLLAGENOSIS 
     
Cup shaped invagination of epidermis filled with plug containing 
keratin and cellular debris 
 
        
Transepidermal elimination                  Inflammatory infiltrate 
of collagen 
 
 
REACTIVE PERFORATING COLLAGENOSIS 
    
Masson trichrome stain for collagen  
 
    
MT stain -Transepidermal                  Verhoeff van Gieson stain 
elimination of collagen                       collagen stained red  
collagen stained blue 
 REACTIVE PERFORATING COLLAGENOSIS 
                   
                   
Transepidermal elimination of collagen fibres 
 
 
KYRLE’S DISEASE 
             
            
Epidermal invagination filled with keratotic plug admixed with 
cellular debris 
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Figure 1: Clinical Types 
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Figure 4: Regional Distribution 
PROFORMA 
Case no: 
Name: 
Age: 
Sex: 
Hosp no: 
Occupation: 
Income: 
Socioeconomic status: 
Address: 
History of skin lesion: 
¾ Age of onset 
¾ Duration 
¾ Site of first lesion 
¾ Evolution of lesion 
¾ Healing spontaneously or with treatment 
¾ Healing with hypo/hyperpigmentation/scarring 
History of pruritus  
History of lesions following trauma 
History of any drug intake for other ailments 
History of any seasonal variation 
General history 
¾ H/o diabetes – age of onset, duration, treatment +/- 
¾ H/o renal disease – age of onset, duration, treatment+/- , dialysis 
+/- 
¾ H/o liver disorder 
¾ H/o endocrine diseases 
¾ H/o infection 
¾ H/o malignancy 
Family history 
Personal history  
¾ Smoking/alcohol 
¾ Marital status 
GENERAL EXAMINATION 
¾ General condition – built, nutrition 
¾ Anemia +/- 
¾ Jaundice+/- 
¾ Cyanosis+/- 
¾ Clubbing +/- 
¾ Pedal edema+/- 
¾ Lymphadenopathy+/- 
¾ Body weight 
¾ Pulse 
¾ Blood pressure 
Cardiovascular system 
Respiratory system 
Abdomen 
Others 
DERMATOLOGICAL EXAMINATION: 
Active skin lesion 
¾ Number, site: 
¾ Morphology: 
¾ Distribution: groups/discrete 
      along lines of trauma 
Healing lesion 
 Hypo/hyperpigmentation 
Scarring 
Palms & soles 
Mucosal lesions 
Hair & nail 
Any other skin lesions 
INVESTIGATIONS: 
¾ Complete hemogram 
¾ Renal function tests 
¾ Liver function tests 
¾ Blood sugar 
¾ Urine examination 
¾ Serum calcium 
¾ Thyroid profile 
¾ Serology – HIV,HBV,HCV 
¾ Skin biopsy 
Site: 
 Findings: 
 Special Stain: 
FINAL DIAGNOSIS: 
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